RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

HUTCHMED (China) P/E 2024

HUTCHMED (China) P/E

-3

HUTCHMED (China) Dividend yield

Ticker

13.HK

ISIN

KYG4672N1198

WKN

A2PJ5B

As of Jun 2, 2024, HUTCHMED (China)'s P/E ratio was -3, a -244.23% change from the 2.08 P/E ratio recorded in the previous year.

The HUTCHMED (China) P/E history

HUTCHMED (China) Aktienanalyse

What does HUTCHMED (China) do?

Hutchison China MediTech Ltd is a Hong Kong-based company specializing in the development and marketing of innovative medications. It has become a significant player in the Asian pharmaceutical industry since its listing on the London Stock Exchange in 2006. The company was founded in 2000 by a team of pharmaceutical experts and scientists and has since evolved into an independent pharmaceutical company. It focuses on developing medications for cancer and inflammatory diseases, incorporating both Western and Chinese medicine practices. Hutchison China MediTech operates in three divisions: innovation, marketing, and manufacturing. It has various medications in its development pipeline, including cancer drugs such as fruquintinib and surufatinib, as well as an anti-inflammatory medication called Naronaprid. The company's headquarters are in Hong Kong, with subsidiaries in Shanghai, Beijing, and Suzhou. Hutchison China MediTech collaborates closely with universities and research institutions globally to advance the development of new medications. Overall, the company has established itself as a significant player in the Asian pharmaceutical industry, operating in a crucial market for the development of innovative medications. HUTCHMED (China) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering HUTCHMED (China)'s P/E Ratio

The Price to Earnings (P/E) Ratio of HUTCHMED (China) is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing HUTCHMED (China)'s P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of HUTCHMED (China) is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in HUTCHMED (China)’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about HUTCHMED (China) Stock

What is the price-to-earnings ratio of HUTCHMED (China)?

The price-earnings ratio of HUTCHMED (China) is currently -3.

How has the price-earnings ratio of HUTCHMED (China) changed compared to last year?

The price-to-earnings ratio of HUTCHMED (China) has increased by -244.23% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of HUTCHMED (China) high compared to other companies?

Yes, the price-to-earnings ratio of HUTCHMED (China) is high compared to other companies.

How does an increase in the price-earnings ratio of HUTCHMED (China) affect the company?

An increase in the price-earnings ratio of HUTCHMED (China) would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of HUTCHMED (China) affect the company?

A decrease in the price-earnings ratio of HUTCHMED (China) would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of HUTCHMED (China)?

Some factors that influence the price-earnings ratio of HUTCHMED (China) are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does HUTCHMED (China) pay?

Over the past 12 months, HUTCHMED (China) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, HUTCHMED (China) is expected to pay a dividend of 0 USD.

What is the dividend yield of HUTCHMED (China)?

The current dividend yield of HUTCHMED (China) is .

When does HUTCHMED (China) pay dividends?

HUTCHMED (China) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of HUTCHMED (China)?

HUTCHMED (China) paid dividends every year for the past 0 years.

What is the dividend of HUTCHMED (China)?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is HUTCHMED (China) located?

HUTCHMED (China) is assigned to the 'Health' sector.

Wann musste ich die Aktien von HUTCHMED (China) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HUTCHMED (China) from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.

When did HUTCHMED (China) pay the last dividend?

The last dividend was paid out on 6/2/2024.

What was the dividend of HUTCHMED (China) in the year 2023?

In the year 2023, HUTCHMED (China) distributed 0 USD as dividends.

In which currency does HUTCHMED (China) pay out the dividend?

The dividends of HUTCHMED (China) are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von HUTCHMED (China)

Our stock analysis for HUTCHMED (China) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HUTCHMED (China) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.